Fig. 2From: Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS studyChanges in natural killer (NK) cell count and proportion in responders and non-responders. Number (upper plot) and percentage (lower plot) of NK cells in responders and non-responders are shown. *p<0.05Back to article page